CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

356

HTML

3420

Figures (1-6)

175

Tables (1-4)

135

Sum=4086

Jun 14, 2005 (publication date) through May 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jun 14, 2005; 11(22): 3339-3345
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3339

Table 1 Determination of CD3CD56 of CIK cells (n = 6).

^aP<0.05 vs others.

Citation: Zhang YS, Yuan FJ, Jia GF, Zhang JF, Hu LY, Huang L, Wang J, Dai ZQ. CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R. World J Gastroenterol 2005; 11(22): 3339-3345
URL: https://www.wjgnet.com/1007-9327/full/v11/i22/3339.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i22.3339